Table 3.
Survival regression models for ESRD patient's mortality.
| Model 1* | Final model** | |||||
|---|---|---|---|---|---|---|
| Adjusted hazard ratio | 95% CI | P | Adjusted hazard ratio |
95% CI | P | |
| Type of vascular access | ||||||
| CVC versus AVF | 2.65 | 1.33–5.30 | 0.006 | 3.03 | 1.49–6.13 | 0.002 |
| C-reactive protein | ||||||
| Q2 versus Q1 | 6.01 | 0.79–46.7 | 0.083 | 4.91 | 0.62–38.6 | 0.130 |
| Q3 versus Q1 | 8.04 | 1.04–62.2 | 0.046 | 8.31 | 1.09–63.1 | 0.041 |
| Q4 versus Q1 | 18.1 | 2.51–130.0 | 0.004 | 17.3 | 2.40–124.9 | 0.005 |
| Triglycerides | ||||||
| Q2 versus Q1 | 0.46 | 0.20–1.02 | 0.057 | 0.48 | 0.19–1.21 | 0.120 |
| Q3 versus Q1 | 0.48 | 0.20–1.13 | 0.093 | 0.48 | 0.17–1.34 | 0.160 |
| Q4 versus Q1 | 0.22 | 0.07–0.75 | 0.015 | 0.18 | 0.05–0.58 | 0.004 |
*Model 1: hazard ratio adjusted for age and previous time on HD; **Final model: hazard ratio adjusted for all variable in the model. CVC: central venous catheter; AVF: arteriovenous fistula; Q: quartile; CI: confidence interval.